Tag: familial hypercholesterolemia treatment market

Familial Hypercholesterolemia Treatment Market is Set To Record Exponential Growth By 2031-End

Post author By administrator
Post date April 29, 2022

According to Fact.MR, Insights of Familial Hypercholesterolemia Treatment Market is a specialized and in-depth study of the industry with a special focus on the Key Trends of Familial Hypercholesterolemia Treatment Market is a Service. The report aims to provide an overview with detailed segmentation by type, application, end use and geography. The global is expected to witness high growth during the forecast period.

A survey offers detailed analysis on key growth drivers of Familial Hypercholesterolemia Treatment Market trends accelerating Familial Hypercholesterolemia Treatment Market sales globally. The survey also gives detailed analysis on the competitive landscape of Familial Hypercholesterolemia Treatment Market identifying key players and analyzing the impact of their growth strategies.

Request Brochure to get extensive insights into the Familial Hypercholesterolemia Treatment Market – https://www.factmr.com/connectus/sample?flag=B&rep_id=5643

Prominent Key players of the Familial Hypercholesterolemia Treatment Market survey report

Key players such as:

AbbVie Inc.
Aegerion Pharmaceuticals
Novartis AG
AstraZeneca Plc.
Merck Company
Pfizer Inc.
Sanofi S.A.
Amgen Inc.
Daiichi Sankyo Company Limited
Esperion Therapeutics
CJ Healthcare

Enquiry Before Buying: https://www.factmr.com/connectus/sample?flag=EB&rep_id=5643

Key Segments of Familial Hypercholesterolemia Treatment Market Covered in the Report

Based on indication type, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Heterozygous familial hypercholesterolemia
- Homozygous familial hypercholesterolemia
Based on the drug, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Statins
- Bile-acid-binding resins
- Cholesterol absorption inhibitors
- Combination cholesterol absorption inhibitor and statin
- Fibrates
- Niacin
- Omega-3 fatty acid supplements
Based on the route of administration, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Oral
- Injectable

Based on the distribution channel, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Institutional Sales
- Hospitals
- Speciality Clinics
- Research Institutes
- Retail Sales
  - Retail Pharmacies
  - Online Pharmacies
Based on the region, the Familial Hypercholesterolemia Treatment Market has been segmented as
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa

The insights for each vendor consists of:

Company profile
SWOT analysis
Main market information
Market share
Revenue, pricing and gross margin

What insights does the Familial Hypercholesterolemia Treatment Market report provide to the readers?

Familial Hypercholesterolemia Treatment Market fragmentation on the basis of product type, end use, and region.
Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
Collaborations, R&D projects, acquisitions, and product launches of each Familial Hypercholesterolemia Treatment Market player.
Various regulations imposed by the governments on the consumption of Familial Hypercholesterolemia Treatment Market in detail.
Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global Familial Hypercholesterolemia Treatment Market.

The report covers following Familial Hypercholesterolemia Treatment Market insights and assessment that are helpful for all participants involved in the Familial Hypercholesterolemia Treatment Market:

Data on recently introduced regulations and their impact on key industries and on demand in Familial Hypercholesterolemia Treatment Market
Latest industry Analysis on Familial Hypercholesterolemia Treatment Market, with key analysis of market drivers, trends, and influencing factors
Key trends Analysis of Familial Hypercholesterolemia Treatment Market and changing consumer preferences in major industries.
Changing Familial Hypercholesterolemia Treatment Market demand and consumption of diverse products
Major trends underlining funding by key investors in numerous countries
New investment opportunities in diverse technology and product or service types
Comprehensive data and Competitive analysis of Familial Hypercholesterolemia Treatment Market major players
Familial Hypercholesterolemia Treatment Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
Familial Hypercholesterolemia Treatment Market demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

Pre Book This Report: https://www.factmr.com/checkout/5643

Questionnaire answered in the Familial Hypercholesterolemia Treatment Market report include:

How the market for Familial Hypercholesterolemia Treatment Market has grown?
What is the present and future outlook of the global Familial Hypercholesterolemia Treatment Market on the basis of region?
What are the challenges and opportunities for the Familial Hypercholesterolemia Treatment Market?
Why the consumption of Familial Hypercholesterolemia Treatment Market highest in region?
In which year segment is expected to overtake segment?

Key Highlights

Sales of Familial Hypercholesterolemia Treatment Market in 2022
Competitive Analysis of Familial Hypercholesterolemia Treatment Market
Demand Analysis of Familial Hypercholesterolemia Treatment Market
Key Trends of Supply Side Analysis of Familial Hypercholesterolemia Treatment Market
Outlook of Familial Hypercholesterolemia Treatment Market
Insights of Familial Hypercholesterolemia Treatment Market
Analysis of Familial Hypercholesterolemia Treatment Market
Survey of Familial Hypercholesterolemia Treatment Market
Size of Familial Hypercholesterolemia Treatment Market

For More Insights of Fact.MR Trending Report:

http://www.globenewswire.com/en/news-release/2018/10/18/1623494/0/en/Hand-Dishwashing-Products-Gain-Upper-Hand-in-Market-despite-High-Demand-for-Dishwashers-says-Fact-MR.html

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Tags Canada Familial Hypercholesterolemia Treatment Market, Demand for Familial Hypercholesterolemia Treatment Market, familial hypercholesterolemia treatment market, Familial Hypercholesterolemia Treatment Market Insights, Familial Hypercholesterolemia Treatment Market sales, Familial Hypercholesterolemia Treatment Market Report, Familial Hypercholesterolemia Treatment Market Analysis, Familial Hypercholesterolemia Treatment Market Demand, Familial Hypercholesterolemia Treatment Market Forecast, Familial Hypercholesterolemia Treatment Market Growth, Familial Hypercholesterolemia Treatment Market Share, Familial Hypercholesterolemia Treatment Market Size, Familial Hypercholesterolemia Treatment Market Trends

Pharmaceutical

Increased Awareness Of Skin Conditions & Potential Treatments Among The Population Are Fuelling The Immunodermatology Market

Post author By administrator
Post date January 6, 2022

Familial hypercholesterolemia is a genetic condition caused due to increased levels to LDL i.e. low-density lipoprotein into the blood vessels. Population suffering from familial hypercholesterolemia is expected to be at higher risk of developing cardiac risk and later stage. Increasing diagnosis and treatment adoption rate is projected to grow familial hypercholesterolemia treatment market in the coming decade. According to the National Institutes of Health, for every 100 people there is 0.3% prevalence of a heterozygous form of familial hypercholesterolemia. On the other hand, a homozygous form of familial hypercholesterolemia occurs in 1 in million population.

Request For Sample – https://www.factmr.com/connectus/sample?flag=Srep_id=5643

Key Segments of Familial Hypercholesterolemia Treatment Market Covered in the Report

Based on indication type, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Heterozygous familial hypercholesterolemia
- Homozygous familial hypercholesterolemia
Based on the drug, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Statins
- Bile-acid-binding resins
- Cholesterol absorption inhibitors
- Combination cholesterol absorption inhibitor and statin
- Fibrates
- Niacin
- Omega-3 fatty acid supplements
Based on the route of administration, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Oral
- Injectable

Based on the distribution channel, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Institutional Sales
- Hospitals
- Speciality Clinics
- Research Institutes
- Retail Sales
  - Retail Pharmacies
  - Online Pharmacies
Based on the region, the Familial Hypercholesterolemia Treatment Market has been segmented as
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa

Request Customized Report as Per Your Requirements https://www.factmr.com/connectus/sample?flag=RC&rep_id=5643

Competitive Landscape

Key players such as:

AbbVie Inc.
Aegerion Pharmaceuticals
Novartis AG
AstraZeneca Plc.
Merck Company
Pfizer Inc.
Sanofi S.A.
Amgen Inc.
Daiichi Sankyo Company Limited
Esperion Therapeutics
CJ Healthcare
others are actively involved in offering Familial Hypercholesterolemia for different applications.

What strategies are the Key Players adopting for Increasing their Market Share in the Familial Hypercholesterolemia Treatment Market?

The manufacturers involved in the production of familial hypercholesterolemia treatment drugs are carrying out different product portfolio expansion strategies for increasing their market share in the global familial hypercholesterolemia treatment market. Key players are expanding their manufacturing facilities to serve the increasing demand for Familial Hypercholesterolemia Treatment. Key players are focussed towards development and launch of new products into familial hypercholesterolemia treatment market.

In January 2020, Novartis AG announced its acquisition of The Medicines Company through Medusa Merger Corporation. The Medicines Company has further become an indirect wholly-owned subsidiary of Novartis.
The acquisition of The Medicines Company into Novartis Pharmaceuticals has led to its product portfolio expansion with atherosclerotic cardiovascular disease or familial hypercholesterolemia therapeutic drugs segment.
On the other hand, in July 2016 Madrigal Pharmaceuticals and Synta Pharmaceutical Corporation entered into a collaboration for developing drugs used in cardiovascular, metabolic and liver diseases along with NASH and heterozygous/homozygous familial hypercholesterolemia with a total of US$ 40 million capital dedicated for research and development activities.
For instance, in October 2020 Novartis International AG announced it received positive response from European Medicines Agency (EMA) for marketing of its drug Leqvio (inclisiran) which is used in treatment of adults suffering from hypercholesterolemia or mixed dyslipidemia. Inclisiran is based on small interfering RNA (siRNA) and makes it a potential drug for European Market.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Tags familial hypercholesterolemia therapeutics, familial hypercholesterolemia treatment demand, familial hypercholesterolemia treatment market, global familial hypercholesterolemia treatment market, heterozygous familial hypercholesterolemia treatment, homozygous familial hypercholesterolemia, Hypercholesterolemia drugs, Statin

Pharmaceutical

Familial Hypercholesterolemia Treatment Market Forecast and Trends Analysis Research Report 2021 to 2031

Post author By administrator
Post date October 13, 2021

The Fact.MR new report on the market survey of Familial Hypercholesterolemia Treatment gives estimations of the Size of Familial Hypercholesterolemia Treatment Market and the overall Familial Hypercholesterolemia Treatment Market share of key regional segments During Forecast 2018 to 2028

Familial Hypercholesterolemia Treatment Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis.

Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections for Sales & Demand of Familial Hypercholesterolemia Treatment, its market share, production footprint, current launches, agreements, ongoing R&D projects, and market strategies.

To get in-depth insights Request for Brochure here :-https://www.factmr.com/connectus/sample?flag=T&rep_id=5643

Key Segments of Familial Hypercholesterolemia Treatment Market Covered in the Report

Based on indication type, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Heterozygous familial hypercholesterolemia
- Homozygous familial hypercholesterolemia
Based on the drug, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Statins
- Bile-acid-binding resins
- Cholesterol absorption inhibitors
- Combination cholesterol absorption inhibitor and statin
- Fibrates
- Niacin
- Omega-3 fatty acid supplements
Based on the route of administration, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Oral
- Injectable

Based on the distribution channel, the Familial Hypercholesterolemia Treatment Market has been segmented as
- Institutional Sales
- Hospitals
- Speciality Clinics
- Research Institutes
- Retail Sales
  - Retail Pharmacies
  - Online Pharmacies
Based on the region, the Familial Hypercholesterolemia Treatment Market has been segmented as
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa

The latest market research report analyzes Familial Hypercholesterolemia Treatment Market demand by Different segments. Providing business leaders with insights On Familial Hypercholesterolemia Treatment And how they can increase their market share.

We leverage space-age industrial and digitalization tools to provide avant-garde actionable Familial Hypercholesterolemia Treatment Market insights to our clients.

SWOT analysis has been performed in the market study to investigate the strengths, weaknesses, opportunities and threats of each player, both at global and regional levels.

The Market insights of Familial Hypercholesterolemia Treatment will improve the revenue impact of businesses in various industries by:

Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Familial Hypercholesterolemia Treatment Market
Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Familial Hypercholesterolemia Treatment market and offers solutions
Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
Helping leading companies make strategy recalibrations ahead of their competitors and peers
Offers insights into promising synergies for top players aiming to retain their leadership position in the market & supply side analysis of Familial Hypercholesterolemia Treatment market .

The latest industry analysis and survey on Familial Hypercholesterolemia Treatment provides sales outlook in 20+ countries, across key categories. Insights and outlook on Familial Hypercholesterolemia Treatment market drivers, trends, and influencing factors are also included in the study.

Request Customized Report as Per Your Requirements :-https://www.factmr.com/connectus/sample?flag=RC&rep_id=5643

This report gives you access to decisive data such as:

Demand of Familial Hypercholesterolemia Treatment Market & Growth drivers
Factors limiting Familial Hypercholesterolemia Treatment market growth
Current key trends of Familial Hypercholesterolemia Treatment Market
Market Size of Familial Hypercholesterolemia Treatment and Familial Hypercholesterolemia Treatment Sales projections for the coming years

The report also offers key trends of Familial Hypercholesterolemia Treatment market and an in-depth analysis of how the projected growth factors will shape the Familial Hypercholesterolemia Treatment market dynamics in the coming years of the forecast period.

Moreover, it also gives meaningful as well as actionable insights on the competitive analysis of Familial Hypercholesterolemia Treatment Market that are developing the current market scenario and which will be lucrative for the future demand of Familial Hypercholesterolemia Treatment Market.

Enquiry Before Buying :-https://www.factmr.com/connectus/sample?flag=EB&rep_id=5643

Crucial insights in Familial Hypercholesterolemia Treatment market research report:

Underlying macro- and microeconomic factors impacting the Sales of Familial Hypercholesterolemia Treatment market.
Basic overview of the Familial Hypercholesterolemia Treatment, including market definition, classification, and applications.
Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
Adoption trend and supply side analysis of Familial Hypercholesterolemia Treatment across various industries.
Important regions and countries offering lucrative opportunities to market stakeholders.

The Demand of Familial Hypercholesterolemia Treatment Market study includes the current market scenario on the global platform and also Sales of Familial Hypercholesterolemia Treatment Market development during the forecast period.

Competitive Landscape

Key players such as:

AbbVie Inc.
Aegerion Pharmaceuticals
Novartis AG
AstraZeneca Plc.
Merck Company
Pfizer Inc.
Sanofi S.A.
Amgen Inc.
Daiichi Sankyo Company Limited
Esperion Therapeutics
CJ Healthcare
others are actively involved in offering Familial Hypercholesterolemia for different applications.

List of the Leading Companies Profiled in the Familial Hypercholesterolemia Treatment Market are:

To provide decision-makers with credible insights on their competitive landscape, the Familial Hypercholesterolemia Treatment Market industry research report includes detailed competitive landscape analysis.

The competitive landscape analysis for Familial Hypercholesterolemia Treatment Market includes detailed profiles of Tier 1, Tier 2, and Tier 3 players. The respective market share of Familial Hypercholesterolemia Treatment manufacturers is provided so business leaders can understand the market scenario.

An assessment on the winning strategies of key Familial Hypercholesterolemia Treatment Market manufacturers is provided, with recommendation on what works well in Familial Hypercholesterolemia Treatment Market landscape.

More Related Reports by Fact.MR On Healthcare Sector:

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Tags familial hypercholesterolemia treatment market, Familial Hypercholesterolemia Treatment Market Analysis, Familial Hypercholesterolemia Treatment Market Forecast, Familial Hypercholesterolemia Treatment Market Key players, Familial Hypercholesterolemia Treatment Market Price, Familial Hypercholesterolemia Treatment Market Share, Familial Hypercholesterolemia Treatment Market Size, Familial Hypercholesterolemia Treatment Market Trend

Pharmaceutical

Familial Hypercholesterolemia Treatment Market to 2031 – Impact Analysis of COVID-19 on the Industry

Post author By administrator
Post date August 3, 2021

The global familial hypercholesterolemia treatment market is exhibiting steady growth and the trend is expected to continue over the forecast period between 2021 and 2031. According to a study by Fact.MR, rising incidence of cardiovascular diseases such as atherosclerosis and stroke has increased the demand for familial hypercholesterolemia treatment.

According to the National Institutes of Health, for every 100 people, there is a 0.3% prevalence of a heterozygous form of familial hypercholesterolemia and homozygous form of familial hypercholesterolemia occurs in 1 in million population.

North America has emerged as the leading market for familial hypercholesterolemia treatment due to increasing incidence of heart diseases and related disorders in the region. Asia, followed by Europe is predicted to witness a high growth rate in coming years in the hypercholesterolemia market.

Request a report sample to gain comprehensive insights at : https://www.factmr.com/connectus/sample?flag=S&rep_id=5643

Key Segments of Familial Hypercholesterolemia Treatment Market Covered in the Report

Based on indication type, the Familial Hypercholesterolemia Treatment Market has been segmented as

Heterozygous familial hypercholesterolemia
Homozygous familial hypercholesterolemia

Based on the drug, the Familial Hypercholesterolemia Treatment Market has been segmented as

Statins
Bile-acid-binding resins
Cholesterol absorption inhibitors
Combination cholesterol absorption inhibitor and statin
Fibrates
Niacin
Omega-3 fatty acid supplements

Based on the route of administration, the Familial Hypercholesterolemia Treatment Market has been segmented as

Oral
Injectable

Based on the distribution channel, the Familial Hypercholesterolemia Treatment Market has been segmented as

Institutional Sales
Hospitals
Speciality Clinics
Research Institutes
Retail Sales
Retail Pharmacies
Online Pharmacies

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=5643

Based on the region, the Familial Hypercholesterolemia Treatment Market has been segmented as

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Competitive Landscape

Key players operating in the familial hypercholesterolemia treatment market profiled by Fact.MR includes Hypercholesterolemia market AstraZeneca Plc., Amgen, Inc., CJ Healthcare, Aegerion Pharmaceuticals, Merck & Co., Esperion Therapeutics, Novartis AG and Pfizer, Eli Lilly and Company, Tekmira Pharmaceuticals Corporation, AbbVie, Inc. New drug launches along with strategic mergers & acquisition remains the core strategy for maintaining their lead in the market.

Explore Fact.MR’s Coverage on the Biospace Domain

Arrhythmogenic Right Ventricular Dysplasia Treatment Market: A recent study by Fact.MR on arrhythmogenic right ventricular dysplasia treatment market offers indepth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Hyperkalaemia Treatment Market: Fact. MR’s extensive coverage on hyperkalaemia treatment market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Atherosclerotic renovascular treatment Market: Fact.MR’s expansive Atherosclerotic renovascular treatment market report sheds light on the prominent dynamics expected to shape future growth

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags familial hypercholesterolemia therapeutics, familial hypercholesterolemia treatment market, global familial hypercholesterolemia treatment market